Cencora, Inc. ABG.F Stock
Cencora, Inc. Price Chart
Cencora, Inc. ABG.F Financial and Trading Overview
| Cencora, Inc. stock price | 218.4 EUR |
| Previous Close | 163.82 EUR |
| Open | 164.38 EUR |
| Bid | 164.7 EUR x 20000 |
| Ask | 168.02 EUR x 20000 |
| Day's Range | 164.38 - 164.38 EUR |
| 52 Week Range | 132.58 - 165.18 EUR |
| Volume | 18 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | 33.92B EUR |
| Beta (5Y Monthly) | 0.522167 |
| PE Ratio (TTM) | 22.767315 |
| EPS (TTM) | 8.56 EUR |
| Forward Dividend & Yield | 1.81 (1.11%) |
| Ex-Dividend Date | May 11, 2023 |
| 1y Target Est | 140.85 EUR |
ABG.F Valuation Measures
| Enterprise Value | 36.46B EUR |
| Trailing P/E | 22.767315 |
| Forward P/E | 15.566288 |
| PEG Ratio (5 yr expected) | 1.1 |
| Price/Sales (ttm) | 0.13704665 |
| Price/Book (mrq) | 118.08909 |
| Enterprise Value/Revenue | 0.147 |
| Enterprise Value/EBITDA | 10.863 |
Trading Information
Cencora, Inc. Stock Price History
| Beta (5Y Monthly) | 0.522167 |
| 52-Week Change | 24.02% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 165.18 EUR |
| 52 Week Low | 132.58 EUR |
| 50-Day Moving Average | 153.2 EUR |
| 200-Day Moving Average | 150.08 EUR |
ABG.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 1 EUR |
| Shares Outstanding | 202.17M |
| Float | 168.34M |
| Short Ratio | N/A |
| % Held by Insiders | 16.95% |
| % Held by Institutions | 77.93% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.89 |
| Trailing Annual Dividend Yield | 1.15% |
| 5 Year Average Dividend Yield | 157.00% |
| Payout Ratio | 0.24260001 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | September 30, 2023 |
Profitability
| Profit Margin | 0.65% |
| Operating Margin (ttm) | 1.04% |
| Gross Margin | 3.40% |
| EBITDA Margin | 1.35% |
Management Effectiveness
| Return on Assets (ttm) | 2.79% |
| Return on Equity (ttm) | 221.03% |
Income Statement
| Revenue (ttm) | 247.54B EUR |
| Revenue Per Share (ttm) | 1203.91 EUR |
| Quarterly Revenue Growth (yoy) | 9.90% |
| Gross Profit (ttm) | 8.33B EUR |
| EBITDA | 3.36B EUR |
| Net Income Avi to Common (ttm) | 1.62B EUR |
| Diluted EPS (ttm) | 7.22 |
| Quarterly Earnings Growth (yoy) | -20.50% |
Balance Sheet
| Total Cash (mrq) | 1.54B EUR |
| Total Cash Per Share (mrq) | 7.6 EUR |
| Total Debt (mrq) | 6.26B EUR |
| Total Debt/Equity (mrq) | 1225.56 EUR |
| Current Ratio (mrq) | 0.887 |
| Book Value Per Share (mrq) | 1.392 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.91B EUR |
| Levered Free Cash Flow (ttm) | 3.69B EUR |
Profile of Cencora, Inc.
| Country | Germany |
| State | PA |
| City | Conshohocken |
| Address | 1 West First Avenue |
| ZIP | 19428-1800 |
| Phone | 610 727 7000 |
| Website | https://www.amerisourcebergen.com |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 39000 |
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Q&A For Cencora, Inc. Stock
What is a current ABG.F stock price?
Cencora, Inc. ABG.F stock price today per share is 218.4 EUR.
How to purchase Cencora, Inc. stock?
You can buy ABG.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cencora, Inc.?
The stock symbol or ticker of Cencora, Inc. is ABG.F.
Which industry does the Cencora, Inc. company belong to?
The Cencora, Inc. industry is Medical Distribution.
How many shares does Cencora, Inc. have in circulation?
The max supply of Cencora, Inc. shares is 199.27M.
What is Cencora, Inc. Price to Earnings Ratio (PE Ratio)?
Cencora, Inc. PE Ratio is 25.51401700 now.
What was Cencora, Inc. earnings per share over the trailing 12 months (TTM)?
Cencora, Inc. EPS is 8.56 EUR over the trailing 12 months.
Which sector does the Cencora, Inc. company belong to?
The Cencora, Inc. sector is Healthcare.